News

Worried that U.S. large-cap stocks won't keep up their winning streak? Diversify with this global value stock ETF that pays impressive dividends.

Bloom Energy Raises Outlook as AI Power Demand Ignites Stock Rally

According to TheFly, several brokerages raised their price targets following Seagate’s Q4 results, with Rosenblatt describing the quarter as a “clean beat-and-raise.”

Retirement means living off your portfolio, not waiting for it to grow, and right now five familiar dividend giants are trading at prices that Wall Street considers deeply undervalued.

SNEX's 75.7% YTD rally reflects strong earnings prospects and diversified growth, but its premium valuation suggests investors should await a pullback.

Generac Holdings Inc. (NYSE:GNRC) reported stronger-than-expected second-quarter earnings on Wednesday, with robust profitability driven by surging demand from data center customers, although revenue came in slightly below Wall Street expectations.

ARK expects more crypto bankruptcies. Cathie Wood's Tesla, SpaceX, and NVIDIA buys show that thesis in action.

Manhattan Associates tops Q2 estimates as cloud revenues jump 26%, boosting sales, profitability and 2026 guidance amid strong growth in performance obligations.

Ford stock rose sharply on Wednesday morning after the Detroit automaker reported mixed second-quarter results and raised its full-year guidance, earnings a quick upgrade to buy from Citi. The analyst's note cited improving momentum and placed a price target at 20, 34% above where Ford stock ended Tuesday. Shares of Ford were up around 5.5% in Wednesday's premarket trading, according to MarketSurge.

Boston Scientific (NYSE:BSX) shares rose more than 3% in pre-market trading on Wednesday after the medical device manufacturer reported second-quarter earnings and revenue that exceeded Wall Street expectations, supported by broad-based growth across its business. The company reported earnings of $0.

Lilly's pipeline is on track to pick up a handful of interesting new programs.

SoFi Technologies (SOFI) delivered earnings and revenue surprises of +9.09% and +8.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

General Dynamics (GD) delivered earnings and revenue surprises of +7.34% and +4.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ADP (ADP) delivered earnings and revenue surprises of +1.93% and +0.87%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.

HF Sinclair surpasses Q2 2026 earnings and revenue estimates as stronger refining margins, higher throughput drove growth.

Biogen (NASDAQ:BIIB) reported stronger-than-expected second-quarter results on Wednesday, with revenue and adjusted earnings exceeding Wall Street forecasts as its expanding portfolio of growth products continued to offset weakness in its legacy multiple sclerosis business. The biotechnology company posted revenue of $2.

Biotech company Biogen (NASDAQ:BIIB) announced better-than-expected revenue in Q2 CY2026, with sales up 3.4% year on year to $2.74 billion. Its non-GAAP profit of $3.60 per share was 75.8% above analysts’ consensus estimates.

Electrical connector manufacturer Amphenol (NYSE:APH) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 55% year on year to $8.76 billion. On top of that, next quarter’s revenue guidance ($9.35 billion at the midpoint) was surprisingly good and 7.1% above what analysts were expecting. Its non-GAAP profit of $1.35 per share was 13.2% above analysts’ consensus estimates.

Archer Aviation has gone from retail darling to distressed asset trading near multi-year lows, and a short list of corporate giants already has the motive, money, and strategic logic to make a move before someone else does.

Shares of Procter & Gamble declined in premarket trading Wednesday as Wall Street reacted to mixed quarterly earnings and underwhelming profit guidance from the consumer packaged goods company. Procter & Gamble posted core earnings of $1.43 a share for the fiscal fourth quarter, down from $1.48 a year ago but slightly above Wall Street expectations of $1.41. It was a mixed bag for Procter & Gamble’s product categories—which range from baby care to hair care.

Seagate Technology PLC (NASDAQ:STX) shares gained nearly 3% in pre-market trading on Wednesday after the data storage company reported stronger-than-expected fourth-quarter earnings and revenue while issuing first-quarter guidance that significantly exceeded Wall Street forecasts. The company reported adjusted earnings of $5.

Earlier this month, Zacks Equity Research highlighted Sezzle Inc. as an attractive growth-focused payments company, citing a strong Growth Score, a top Zacks Rank, and expectations for earnings per share expansion that outpaces its diversified financials peers. The report also pointed to fast-growing cash flows and recent upward revisions to earnings estimates as key supports for Sezzle’s earnings outlook. Next, we’ll examine how Sezzle’s upgraded earnings estimates and growth profile could...

Oklo (NYSE:OKLO) received startup authorization from the U.S. Department of Energy for its Groves Isotope Test Reactor. The approval completes a key regulatory process and allows Oklo to begin fuel loading, startup testing, and reactor operations. Oklo focuses on advanced nuclear reactors and related services, with the Groves Isotope Test Reactor positioned to support production of high value isotopes for multiple industries. For investors watching the nuclear space, this milestone...

Visa (NYSE:V) reported stronger-than-expected fiscal third-quarter results on Tuesday, with double-digit revenue growth supported by resilient consumer spending and continued strength in cross-border payment activity. The global payments company posted adjusted earnings of $3.

FDA calendars are stacking up fast, obesity Phase 3 data is closing in, and three biotech names spanning the risk spectrum are quietly positioning for a pivotal back half of 2026.

Amazon reported its Q2 earnings after the bell on Thursday.

Amazon reported its Q2 earnings after the bell on Thursday.

Apple reported its Q3 earnings on Thursday.

Energy Transfer continues to grow its already lucrative income stream.